Testing a lung tumor's genome for alterations is helping patients get treatments matched to their disease, US News & World Report says.

About 60 percent of lung adenocarcinomas harbor specific gene mutations that may be key drivers of disease, it says, adding that by targeting these changes, clinicians may be better able to treat the disease.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.